Literature DB >> 16271040

Homology-model-guided site-specific mutagenesis reveals the mechanisms of substrate binding and product-regulation of adenosine kinase from Leishmania donovani.

Rupak Datta1, Ishita Das, Banibrata Sen, Anutosh Chakraborty, Subrata Adak, Chhabinath Mandal, Alok K Datta.   

Abstract

Despite designating catalytic roles of Asp299 and Arg131 during the transfer of gamma-phosphate from ATP to Ado (adenosine) [R. Datta, Das, Sen, Chakraborty, Adak, Mandal and A. K. Datta (2005) Biochem. J. 387, 591-600], the mechanisms that determine binding of substrate and cause product inhibition of adenosine kinase from Leishmania donovani remained unclear. In the present study, employing homology-model-guided site-specific protein mutagenesis, we show that Asp16 is indispensable, since its replacement with either valine or arginine resulted in a >200-fold increase in K(m) (Ado) with a 1000-fold decrease in k(cat)/K(m), implying its critical importance in Ado binding. Even glutamate replacement was not tolerated, indicating the essentiality of Asp16 in the maintenance of steric complementarity of the binding pocket. Use of 2'or 3'-deoxygenated Ado as substrates indicated that, although both the hydroxy groups play important roles in the formation of the enzyme-Ado complex, the binding energy (DeltaDeltaG(B)) contribution of the former was greater than the latter, suggesting possible formation of a bidentate hydrogen bond between Asp16 and the adenosyl ribose. Interestingly, AMP-inhibition and AMP-binding studies revealed that, unlike the R131A mutant, which showed abrogated AMP-binding and insensitivity towards AMP inhibition despite its unaltered K(m) (Ado), all the Asp16 mutants bound AMP efficiently and displayed AMP-sensitive catalytic activity, suggesting disparate mechanisms of binding of Ado and AMP. Molecular docking revealed that, although both Ado and AMP apparently occupied the same binding pocket, Ado binds in a manner that is subtly different from AMP binding, which relies heavily on hydrogen-bonding with Arg131 and thus creates an appropriate environment for competition with Ado. Hence, besides its role in catalysis, an additional novel function of the Arg131 residue as an effector of product-mediated enzyme regulation is proposed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16271040      PMCID: PMC1386000          DOI: 10.1042/BJ20051513

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Induced fit on sugar binding activates ribokinase.

Authors:  J A Sigrell; A D Cameron; S L Mowbray
Journal:  J Mol Biol       Date:  1999-07-30       Impact factor: 5.469

2.  Enzymatic phosphorylation of adenosine and 2,6-diaminopurine riboside.

Authors:  A KORNBERG; W E PRICER
Journal:  J Biol Chem       Date:  1951-12       Impact factor: 5.157

3.  The enzymatic synthesis of adenylic acid; adenosinekinase.

Authors:  R CAPUTTO
Journal:  J Biol Chem       Date:  1951-04       Impact factor: 5.157

4.  Leishmania mexicana: purine-metabolizing enzymes of amastigotes and promastigotes.

Authors:  H F Hassan; G H Coombs
Journal:  Exp Parasitol       Date:  1985-04       Impact factor: 2.011

5.  Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.

Authors:  M A Schumacher; D M Scott; I I Mathews; S E Ealick; D S Roos; B Ullman; R G Brennan
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

6.  Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.

Authors:  M H Iltzsch; S S Uber; K O Tankersley; M H el Kouni
Journal:  Biochem Pharmacol       Date:  1995-05-17       Impact factor: 5.858

7.  The stereochemical course of thiophosphoryl group transfer catalyzed by adenosine kinase.

Authors:  J P Richard; M C Carr; D H Ives; P A Frey
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

8.  Isolation and characterization of adenosine kinase from Leishmania donovani.

Authors:  A K Datta; D Bhaumik; R Chatterjee
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

9.  Immunochemical and catalytic characteristics of adenosine kinase from Leishmania donovani.

Authors:  D Bhaumik; A K Datta
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

10.  Structure of human adenosine kinase at 1.5 A resolution.

Authors:  I I Mathews; M D Erion; S E Ealick
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

View more
  4 in total

1.  South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.

Authors:  Kiran S Toti; Danielle Osborne; Antonella Ciancetta; Detlev Boison; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2016-07-13       Impact factor: 7.446

2.  Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.

Authors:  Alexandra Lüscher; Pinar Onal; Anne-Marie Schweingruber; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

3.  Bioretrosynthetic construction of a didanosine biosynthetic pathway.

Authors:  William R Birmingham; Chrystal A Starbird; Timothy D Panosian; David P Nannemann; T M Iverson; Brian O Bachmann
Journal:  Nat Chem Biol       Date:  2014-03-23       Impact factor: 15.040

4.  Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase.

Authors:  Rajiv K Kar; Md Yousuf Ansari; Priyanka Suryadevara; Bikash R Sahoo; Ganesh C Sahoo; Manas R Dikhit; Pradeep Das
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.